Investigation Overview
August 3, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Cytec Industries Inc (NYSE:CYT), was launched concerning whether the takeover of Cytec Industries Inc by Solvay for $75.25 per share is unfair to NYSE:CYT stockholders.
The investigation by a law firm concerns whether certain officers and directors of Cytec Industries Inc breached their fiduciary duties owed to NYSE:CYT investors in connection with the proposed acquisition.
On July 29, 2015 Cytec Industries Inc. (NYSE:CYT) announced that it has entered into a merger agreement with Brussels-based Solvay. Under the terms of the proposed transaction shareholders of Cytec Industries Inc (NYSE:CYT) will receive $75.25 per NYSE:CYT share they hold.
However, the investigation concerns whether the offer is unfair to NYSE:CYT stockholders. More specifically, the investigation concerns whether the Cytec Industries Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.